IL6R and cardiovascular disorder: A recent study suggested that CHIP carriers with genetic deficiency of IL-6 signaling (by carrying IL6R p.Asp358Ala versus wild-type) had a greater reduction in cardiovascular disease risk when compared to non-CHIP carriers with genetic IL-6 signaling deficiency [4].